arsenic trioxide has been researched along with Acute Disease in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.33) | 18.7374 |
| 1990's | 4 (13.33) | 18.2507 |
| 2000's | 21 (70.00) | 29.6817 |
| 2010's | 3 (10.00) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, X; Hua, J; Xie, Y | 1 |
| Ji, L; Jiang, Y | 1 |
| Gabrilove, J; Gong, P; Jing, Y; Li, Y; Wang, R; Waxman, S | 1 |
| Angelopoulou, MK; Asimakopoulos, JV; Kelepesis, G; Konstantopoulos, K; Koutsi, C; Meletis, J; Papageorgiou, L; Petevi, K; Plata, E; Tsaftaridis, P; Vassilakopoulos, TP | 1 |
| Alkis, N; Armagan, E; Dolar, E; Esen, M; Olmez, O; Yilmaz, Y | 1 |
| Higashi, Y; Pallis, M; Russell, N; Turzanski, J | 1 |
| Chaudhary, PM; Matta, H; Sun, Q | 1 |
| Au, WY; Kou, M; Kumana, CR; Kwong, YL; Lam, CW; Lee, NS; Mak, RW | 1 |
| Ravandi, F; van Besien, K | 1 |
| Akhand, AA; Emi, N; Hossain, K; Kajiguchi, T; Nakashima, I; Naoe, T; Saito, H; Yamamoto, K | 1 |
| Nakamura, S; Nakao, S; Ohtake, S; Okumura, H; Zhu, J | 1 |
| Lin, MF; Wei, GQ; Zhang, SL; Zou, DB | 1 |
| Boehlke, L; Frater, JL; Nabhan, C; Parmar, S; Raji, A; Riley, M; Rundhaugen, LM; Tallman, MS | 1 |
| Dawson, AH; Isbister, GK; Whyte, IM | 1 |
| Desmond, JC; Hewison, M; Hughes, SV; Koeffler, HP; Kumagai, T; O'Kelly, J; Shih, LY | 1 |
| Chow, J; Huang, M; Lee, C; Lin, C; Lin, Y; Liu, C; Liu, HE | 1 |
| Akioka, T; Hanafusa, T; Hara, S; Oka, T; Tsuji, M; Yamano, T; Yokote, T | 1 |
| Andreeff, M; Carew, JS; Huang, P; Keating, MJ; McQueen, TJ; Pelicano, H; Plunkett, W | 1 |
| Bagic, A; Kessler, CM; Lupu, V; Tornatore, C | 1 |
| Kwong, YL; Leung, J; Pang, A; Tse, EW; Yuen, WH | 1 |
| Akar, U; Berestein, GL; Colburn, N; Danilenko, M; Kornblau, S; Ozpolat, B; Steiner, M; Tirado-Gomez, M; Zorrilla-Calancha, I | 1 |
| Berman, JN; Look, AT | 1 |
| Calbi, G; Calbi, P; Marcovigi, P; Valtancoli, E | 1 |
| Chang, CS; Chen, YC; Chou, WC; Chung, CY; Huang, SF; Huang, SY; Kuo, TL; Shen, MC; Tang, JL; Tien, HF; Wang, CH; Yao, YT | 1 |
| Chiodino, C; Donelli, A; Panissidi, T; Roncaglia, R; Torelli, G | 1 |
| Bachleitner-Hofmann, T; Gisslinger, B; Gisslinger, H; Grumbeck, E | 1 |
| Huang, X | 1 |
| Jin, H; Lou, F; Yu, L | 1 |
| Budd, AJ; Gwilt, DJ; Jolliffe, DM | 1 |
| Arcangeli, A; Cavaliere, F; de Francisci, G; De Giacomo, M; Magalini, SI | 1 |
2 review(s) available for arsenic trioxide and Acute Disease
| Article | Year |
|---|---|
P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype.
Topics: Acute Disease; Adult; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Division; Ceramides; Child; Cyclosporine; Cyclosporins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Leukemia, Myeloid; Lovastatin; Multicenter Studies as Topic; Neoplasm Proteins; Oxides; Phenotype; Protein Kinase C; Randomized Controlled Trials as Topic; Signal Transduction; Tumor Cells, Cultured | 2002 |
Targeting transcription factors in acute leukemia in children.
Topics: Acute Disease; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Child; DNA Methylation; Drug Delivery Systems; Histone Deacetylase Inhibitors; Humans; Leukemia; Oxides; Transcription Factors; Tretinoin | 2007 |
1 trial(s) available for arsenic trioxide and Acute Disease
| Article | Year |
|---|---|
Phase II trial of arsenic trioxide in relapsed and refractory acute myeloid leukemia, secondary leukemia and/or newly diagnosed patients at least 65 years old.
Topics: Acute Disease; Aged; Aged, 80 and over; Arsenic Trioxide; Arsenicals; ATP Binding Cassette Transporter, Subfamily B; Bone Marrow Examination; Disease Progression; Drug Resistance, Multiple; Female; Glycoproteins; Humans; Leukemia, Myeloid; Male; Middle Aged; Neoplasms, Second Primary; Oxides; Salvage Therapy; Treatment Outcome | 2004 |
27 other study(ies) available for arsenic trioxide and Acute Disease
| Article | Year |
|---|---|
A Rare Morphology Resembling APL with t (11;12) (p15;q13) in Acute Myeloid Leukemia: Case Report and Literature Review.
Topics: Acute Disease; Antineoplastic Agents; Arsenic Trioxide; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 12; Humans; Leukemia, Myeloid; Male; Oncogene Proteins, Fusion; Review Literature as Topic; Translocation, Genetic; Treatment Outcome; Tretinoin; Young Adult | 2019 |
Severe Wernicke encephalopathy and acute pancreatitis due to all-trans-retinoic acid and arsenic trioxide during treatment of acute promyelocytic leukaemia: a case report.
Topics: Acute Disease; Arsenic Trioxide; Arsenicals; Female; Humans; Leukemia, Promyelocytic, Acute; Middle Aged; Oxides; Pancreatitis; Tretinoin; Wernicke Encephalopathy | 2020 |
Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells.
Topics: Acute Disease; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Cell Line, Tumor; fms-Like Tyrosine Kinase 3; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Sorafenib; Synthetic Lethal Mutations; Tandem Repeat Sequences; THP-1 Cells; Xenograft Model Antitumor Assays | 2018 |
Recurrent acute myopericarditis without effusion during ATRA induction and ATO salvage of APL: a variant form of the differentiation syndrome?
Topics: Acute Disease; Adolescent; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Electrocardiography; Humans; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Male; Oxides; Pericarditis; Remission Induction; Tretinoin | 2017 |
Acute arsenic self-poisoning for suicidal purpose in a dentist: a case report.
Topics: Acute Disease; Aged; Arsenic Poisoning; Arsenic Trioxide; Arsenicals; Charcoal; Chelating Agents; Chelation Therapy; Dimercaprol; Gastric Lavage; Humans; Intubation, Gastrointestinal; Male; Oxides; Suicide, Attempted; Treatment Outcome | 2009 |
The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation.
Topics: Acetylcysteine; Acute Disease; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-X Protein; Cell Transformation, Viral; Enzyme Activation; Gene Expression Regulation, Viral; Granulocyte-Macrophage Colony-Stimulating Factor; Herpesvirus 8, Human; Humans; I-kappa B Proteins; Leukemia, Myeloid; Leupeptins; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; NF-kappa B; Oxides; Proto-Oncogene Proteins c-bcl-2; Recombinant Fusion Proteins; Recombinant Proteins; Rhadinovirus; Transcription, Genetic; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Viral Proteins | 2003 |
Systemic availability of arsenic from oral arsenic-trioxide used to treat patients with hematological malignancies.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Area Under Curve; Arsenic Trioxide; Arsenicals; Biological Availability; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid; Male; Middle Aged; Oxides; Time Factors | 2002 |
Clinical activity of arsenic trioxide in Burkitt-like lymphoma.
Topics: Acute Disease; Adult; Antigens, CD; Antineoplastic Agents; Antioxidants; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Burkitt Lymphoma; Drug Therapy, Combination; Female; Humans; L-Lactate Dehydrogenase; Leukemia, Lymphoid; Oxides; Salvage Therapy; Treatment Outcome | 2003 |
Sustained activation of c-jun-terminal kinase (JNK) is closely related to arsenic trioxide-induced apoptosis in an acute myeloid leukemia (M2)-derived cell line, NKM-1.
Topics: Acute Disease; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase 3; Caspases; Chronic Disease; Enzyme Activation; Humans; Hydrogen Peroxide; Intracellular Membranes; JNK Mitogen-Activated Protein Kinases; K562 Cells; Leukemia, Myeloid; Membrane Potentials; Mitochondria; Mitogen-Activated Protein Kinases; Oxides; Reactive Oxygen Species; Tumor Cells, Cultured | 2003 |
The molecular mechanism of arsenic trioxide-induced apoptosis and oncosis in leukemia/lymphoma cell lines.
Topics: Acute Disease; Amino Acid Chloromethyl Ketones; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Division; Cysteine Proteinase Inhibitors; Down-Regulation; Fas Ligand Protein; fas Receptor; HL-60 Cells; Humans; K562 Cells; Leukemia, Myeloid; Membrane Glycoproteins; Oxides; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Up-Regulation | 2003 |
[Cytotoxic effects of arsenic trioxide in combination with chemotherapeutic drugs on acute non-promyelocytic leukemia cells].
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Child; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Leukemia; Male; Middle Aged; Oxides | 2004 |
Arsenic trioxide poisoning: a description of two acute overdoses.
Topics: Acute Disease; Adult; Antidotes; Arsenic Poisoning; Arsenic Trioxide; Arsenicals; Drug Overdose; Feces; Humans; Male; Oxides; Powders; Succimer; Suicide, Attempted; Time Factors | 2004 |
19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cell Differentiation; Cell Growth Processes; Cell Line, Tumor; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Screening Assays, Antitumor; Drug Synergism; Ergocalciferols; Gene Expression; HL-60 Cells; Humans; Leukemia, Myeloid; Mitochondria; Neoplasm Proteins; Oncogene Proteins, Fusion; Oxides; Steroid Hydroxylases; Vitamin D3 24-Hydroxylase | 2005 |
Increased cellular glutathione and protection by bone marrow stromal cells account for the resistance of non-acute promylocytic leukemia acute myeloid leukemia cells to arsenic trioxide in vivo.
Topics: Acute Disease; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Marrow Cells; Buthionine Sulfoximine; Cell Count; Cell Line, Tumor; Coculture Techniques; Disease Models, Animal; Drug Resistance, Neoplasm; Glutathione; Humans; Injections, Intraperitoneal; Leukemia, Myeloid; Mice; Mice, Inbred NOD; Mice, SCID; Oxides; Stromal Cells; Treatment Failure | 2006 |
[Acute pancreatitis during the treatment of relapsed acute promyelocytic leukemia with As2O3].
Topics: Acute Disease; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Humans; Leukemia, Promyelocytic, Acute; Male; Oxides; Pancreatitis; Recurrence | 2006 |
Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C.
Topics: Acute Disease; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Benzoquinones; Cytarabine; DNA; Drug Administration Schedule; Drug Antagonism; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; G1 Phase; HeLa Cells; HSP90 Heat-Shock Proteins; Humans; Jurkat Cells; Lactams, Macrocyclic; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Oxides; Sensitivity and Specificity; Structure-Activity Relationship; Tumor Cells, Cultured | 2006 |
Iatrogenic arsenic induced Mees' lines.
Topics: Acute Disease; Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Humans; Leukemia, Myeloid; Male; Nail Diseases; Oxides | 2006 |
Relationship of expression of aquaglyceroporin 9 with arsenic uptake and sensitivity in leukemia cells.
Topics: Acute Disease; Aquaporins; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Gene Expression Profiling; Humans; K562 Cells; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Oxides; Point Mutation; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Tretinoin; Up-Regulation | 2007 |
Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Topics: Acute Disease; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Granulocytes; HL-60 Cells; Humans; Leukemia, Myeloid; Macrophages; Monocytes; Oxides; Protein Transport; Proto-Oncogene Proteins c-akt; RNA-Binding Proteins; RNA, Small Interfering; Tretinoin | 2007 |
[Acute poisoning from arsenous anhydride ingestion. A clinical case].
Topics: Acute Disease; Adolescent; Arsenic Poisoning; Arsenic Trioxide; Arsenicals; Feces; Female; Humans; Oxides; Poisoning; Suicide, Attempted; Time Factors | 1993 |
Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia.
Topics: Acute Disease; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Chronic Disease; Humans; Leukemia, Promyelocytic, Acute; Oxides; Recurrence | 1998 |
Might arsenic trioxide be useful in the treatment of advanced myelodysplastic syndromes?
Topics: Acute Disease; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Bone Marrow Cells; Cell Culture Techniques; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Inhibitors; Humans; Leukemia, Myeloid; Leukocytes, Mononuclear; Myelodysplastic Syndromes; Oxides | 2000 |
Arsenic trioxide and ascorbic acid: synergy with potential implications for the treatment of acute myeloid leukaemia?
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Drug Synergism; Drug Therapy, Combination; Humans; In Situ Nick-End Labeling; Leukemia, Myeloid; Middle Aged; Oxides; Tumor Cells, Cultured | 2001 |
[Regulation of arsenic trioxide-inducing apoptosis].
Topics: Acute Disease; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase Inhibitors; HL-60 Cells; Humans; Leukemia, Myeloid; Oligopeptides; Oxides; Tretinoin; Tumor Cells, Cultured | 1999 |
[p15 gene expression in acute lymphoblastic leukemia cell line Molt4 induced by arsenic trioxide].
Topics: Acute Disease; Arsenic Trioxide; Arsenicals; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p15; DNA Methylation; Gene Expression Regulation, Leukemic; Humans; Leukemia, Lymphoid; Oxides | 2001 |
Massive acute arsenic poisoning.
Topics: Acute Disease; Adult; Arsenic Poisoning; Arsenic Trioxide; Arsenicals; Charcoal; Dimercaprol; Fluid Therapy; Humans; Male; Oxides; Poisoning; Suicide | 1991 |
[Acute poisoning with arsenous anhydride].
Topics: Acute Disease; Adult; Arsenic Poisoning; Arsenic Trioxide; Arsenicals; Humans; Male; Oxides | 1985 |